CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.
about
Centrosome - a promising anti-cancer targetTargeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerPathogenesis and heterogeneity of ovarian cancer.High-grade serous carcinoma of tubo-ovarian origin: recent developments.Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance.Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis.Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells.
P2860
Q28077520-E82F3851-CB50-4E84-8ABD-0E218B8720FCQ33689051-23AADE8D-EAFC-4FC1-AE91-E7A2AF81990DQ37546692-E105DB25-030F-443D-9297-618B18F5C8E0Q38687061-A2BF378C-BC57-409E-B2AC-9F47D3DA7F53Q39068123-C7D4789B-2D0B-4FAA-B2C7-CD0D282956D9Q41294690-C169785C-7E0E-413B-95B9-01C7C16A3B66Q42365333-FE6B5C94-8CFE-4F35-A4F5-0694132326D2Q42379619-E8AB61E9-D0B4-4C88-B2E4-D3454D74BE14Q46303839-13994D08-ED6F-42FC-ADA2-982AD64B1A1FQ46469350-4C6258B3-0BE6-41EB-AE32-DB63C04FE4AEQ47610274-C11CCAA2-8440-4519-9D59-5FFC4FC4CC2DQ48124146-90F12015-03D1-4846-BFB1-1E203AE3FF6BQ52725338-F82A84B4-8ADF-486A-AC08-5472A0895403
P2860
CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
CCNE1 amplification and centro ...... n high-grade serous carcinoma.
@en
CCNE1 amplification and centro ...... n high-grade serous carcinoma.
@nl
type
label
CCNE1 amplification and centro ...... n high-grade serous carcinoma.
@en
CCNE1 amplification and centro ...... n high-grade serous carcinoma.
@nl
prefLabel
CCNE1 amplification and centro ...... n high-grade serous carcinoma.
@en
CCNE1 amplification and centro ...... n high-grade serous carcinoma.
@nl
P2093
P2860
P1433
P1476
CCNE1 amplification and centro ...... an high-grade serous carcinoma
@en
P2093
Ann Smith Sehdev
Asli Bahadirli-Talbott
Elisabetta Kuhn
Ie-Ming Shih
Kai Doberstein
Robert J Kurman
Tian-Li Wang
P2860
P2888
P304
P356
10.1038/MODPATHOL.2016.101
P577
2016-07-22T00:00:00Z